|
|
Line 144: |
Line 144: |
| <div class="col-lg-7 ml-lg-auto"> | | <div class="col-lg-7 ml-lg-auto"> |
| <div class="pt-lg-lg pl-lg-7"> | | <div class="pt-lg-lg pl-lg-7"> |
− | <p class="lead text-gray my-4">We were very excited to get contacted by this year’s XMU iGEM team who are working on their own assay called the Aptamer Based Cell-free Detection system (ABCD system). They are using Cas12a in an ingenuitive way to detect proteins through | + | <p class="lead text-gray my-4">We were very excited to get contacted by this year’s <a href="https://2018.igem.org/Team:XMU-China" target="=_blank"><span style="color:blue">XMU iGEM</span></a>team who are working on their own assay called the Aptamer Based Cell-free Detection system (ABCD system). They are using Cas12a in an ingenuitive way to detect proteins through |
| the intermediary of aptamers. Indeed, aptamers have the capacity of recognizing a specific protein and by doing so will release a ssDNA that will be recognized by Cas12a. Since both of our teams are working on a Cas12a detection using | | the intermediary of aptamers. Indeed, aptamers have the capacity of recognizing a specific protein and by doing so will release a ssDNA that will be recognized by Cas12a. Since both of our teams are working on a Cas12a detection using |
| fluorophore quencher it was natural for us to give them all the knowledge we had gathered over the summer about our Cas12a assay. | | fluorophore quencher it was natural for us to give them all the knowledge we had gathered over the summer about our Cas12a assay. |
Line 174: |
Line 174: |
| <br> | | <br> |
| <div class="col-lg-12"> | | <div class="col-lg-12"> |
− | The collaboration with the Athens team started early in the summer, after members of both teams identified multiple shared attributes between the two projects, namely cell free expression, and diagnostic kit development. Thus, the contact started with | + | The collaboration with the <a href="https://2018.igem.org/Team:Athens" target="=_blank"><span style="color:blue">Athens IGEM</span></a>team started early in the summer, after members of both teams identified multiple shared attributes between the two projects, namely cell free expression, and diagnostic kit development. Thus, the contact started with |
| multiple video conferences over the summer. These conferences discussed iGEM EPFL’s experience with cell free systems optimization, especially with linear DNA expression templates. Moreover, the EPFL team benefited from Athens’ team knowledge | | multiple video conferences over the summer. These conferences discussed iGEM EPFL’s experience with cell free systems optimization, especially with linear DNA expression templates. Moreover, the EPFL team benefited from Athens’ team knowledge |
| and experience with kit design to start the kit design for our diagnostic tool. The collaboration finally materialized with Yannis from iGEM Athens visiting the EPFL team and spending some time with us in the lab. The discussion revolved mainly | | and experience with kit design to start the kit design for our diagnostic tool. The collaboration finally materialized with Yannis from iGEM Athens visiting the EPFL team and spending some time with us in the lab. The discussion revolved mainly |
Line 195: |
Line 195: |
| <div class="col-lg-7 ml-lg-auto"> | | <div class="col-lg-7 ml-lg-auto"> |
| <div class="pt-lg-lg pl-lg-7"> | | <div class="pt-lg-lg pl-lg-7"> |
− | <p class="lead text-gray my-4">We had the privilege of collaborating with Great Bay China, a high School team from Shenzhen. We received numerous tips and good advice about poster design, the flow that iGEM presentations should have as well as information about common | + | <p class="lead text-gray my-4">We had the privilege of collaborating with <a href="https://2018.igem.org/Team:GreatBay_China" target="=_blank"><span style="color:blue">Great Bay China</span></a>, a high School team from Shenzhen. We received numerous tips and good advice about poster design, the flow that iGEM presentations should have as well as information about common |
| pitfalls and how to avoid them. On our side, we were able to help them with identifying backup plans to perform the last step of their transformation chemically, since the enzyme performing this action is unknown to this day. | | pitfalls and how to avoid them. On our side, we were able to help them with identifying backup plans to perform the last step of their transformation chemically, since the enzyme performing this action is unknown to this day. |
| </p> | | </p> |